Skip to content
The Policy VaultThe Policy Vault

Rezurock (belumosudil) — Point32Health

chronic graft-versus-host disease (cGVHD)

Initial criteria

  • Documented diagnosis of chronic graft versus host disease
  • Patient age ≥ 12 years
  • Documentation of failure with at least two prior lines of systemic therapies (e.g., corticosteroids)